TherapeuticsMD, Inc. Balance Sheet
TXMD|14 years of annual SEC 10-K data (FY2011-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
TherapeuticsMD, Inc. had $39M in total assets and $29M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.1M | - | - | - | - | - | - | - | - | - | - | - | - | $422.9K |
| Accounts Receivable | - | - | - | $36.2M | $32.4M | $24.4M | $11.1M | $4.3M | $4.5M | $3.0M | $2.2M | $1.7M | $606.6K | $26.7K |
| Inventory | - | - | - | $7.6M | $8.0M | $11.9M | $3.3M | $1.5M | $1.1M | $690.2K | $1.2M | $1.0M | $1.6M | $588.1K |
| Current Assets | $12.3M | $11.8M | $55.4M | $119.5M | $128.4M | $208.4M | $186.8M | $139.6M | $139.4M | $70.7M | $56.2M | $59.4M | $4.5M | $1.2M |
| PP&E (Net) | - | - | $78.0K | $1.2M | $1.9M | $2.5M | $472.7K | $437.1K | $516.8K | $198.6K | $63.3K | $61.3K | $65.7K | $70.1K |
| Total Assets | $38.8M | $43.3M | $90.5M | $169.5M | $181.6M | $266.0M | $212.0M | $143.2M | $142.5M | $73.7M | $59.1M | $62.0M | $5.8M | $1.4M |
| Current Liabilities | $5.2M | $6.9M | $46.8M | $252.9M | $59.2M | $53.0M | $41.1M | $13.3M | $15.0M | $10.7M | $10.7M | $7.3M | $3.5M | $3.2M |
| Total Debt | - | - | - | $188.3M | $237.7M | $194.6M | $73.4M | - | - | - | - | - | - | - |
| Shareholders' Equity | $29.3M | $35.1M | -$93.6M | -$124.0M | $97.5M | $129.9M | $127.5M | $63.1M | $48.4M | $54.7M | -$1.4M | -$1.4M | -$1.7M | -$1.7M |